OPKO HEALTH, INC.

For the period ended Jun 30, 2026. Filed Jul 27, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 27, 2026

OPK$1.710.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets as of June 30, 2026

CONDENSED CONSO LIDATED BALANCE SHEET

(In thousands, except share and per share data)

	June 30, 2026	December 31, 2025
ASSETS
Current assets:
Cash, cash equivalents and current restricted cash	$300,761	$369,074
Accounts receivable, net	81,886	90,255
Inventory, net	61,851	65,823
Other current assets and prepaid expenses	55,738	56,729
Total current assets	500,236	581,881
Property, plant and equipment, net	71,454	73,926
Intangible assets, net	477,566	516,276
In-process research and development	195,000	195,000
Goodwill	481,515	484,289
Investments	40,217	14,168
Operating lease right-of-use assets	43,971	46,930
Other assets	19,494	19,474
Total assets	$1,829,453	$1,931,944
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$50,043	$41,103
Accrued expenses	77,757	84,406
Current maturities of operating leases	11,009	10,917
Current portion of lines of credit and notes payable	10,558	10,251
Total current liabilities	149,367	146,677
Operating lease liabilities	33,980	36,815
Long term portion of convertible notes	89,857	85,020
Senior secured royalty financing	246,854	246,433
Deferred tax liabilities	108,230	126,241
Other long-term liabilities	16,999	22,799
Total long-term liabilities	495,920	517,308
Total liabilities	645,287	663,985
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively	7,762	7,900
Treasury Stock - 30,174,907, and 30,849,907 shares at June 30, 2026 and December 31, 2025, respectively	(2,363)	(3,176)
Additional paid-in capital	3,561,114	3,574,942
Accumulated other comprehensive loss	(28,393)	(21,017)
Accumulated deficit	(2,353,954)	(2,290,690)
Total shareholders’ equity	1,184,166	1,267,959
Total liabilities and equity	$1,829,453	$1,931,944

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.